Schedule 13G ownership disclosure

EPIRUS BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 29428P107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
133
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137774-16-000252
Form type
SC 13G/A
Filer
EPIRUS Biopharmaceuticals, Inc.
CIK
CIK 1135906
Filed
Jul 11, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub